Skip to main content
FBLG logo

FBLG · FibroBiologics, Inc.

$0.84 -0.01 (-0.60%) At close · Jul 17
Market Cap
$4.35M
Shares
5,208,915

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
44/100
Short interest 2.6% of shares — P56 Days to cover 1.0 — P15 Price vs VWAP -25.0% — P13 Short-volume trend +1.4% — P57 Short interest change -0.9% — P41 Worst FTD 0.66% of shares — P91

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 135,794 137,027 -1,233 1.00
2026-06-15 137,027 135,591 +1,436 1.00
2026-05-29 135,591 237,640 -102,049 1.36
2026-05-15 237,640 118,414 +119,226 1.00
2026-04-30 118,414 99,974 +18,440 1.00
2026-04-15 99,974 209,586 -109,612 1.00
2026-03-31 209,586 873,527 -663,941 1.00
2026-03-13 43,676 33,564 +10,112 1.00
2026-02-27 33,564 31,501 +2,063 1.15
2026-02-13 31,501 42,587 -11,086 1.00
2026-01-30 42,587 18,643 +23,944 1.24
2026-01-15 18,643 45,354 -26,711 1.00
2025-12-31 45,354 39,767 +5,587 1.00
2025-12-15 39,767 69,482 -29,715 1.00
2025-11-28 69,482 70,540 -1,058 1.00
2025-11-14 70,540 90,576 -20,036 1.36
2025-10-31 90,576 101,497 -10,921 1.84
2025-10-15 101,497 48,293 +53,204 1.64
2025-09-30 48,293 48,528 -235 1.10
2025-09-15 48,528 45,877 +2,651 2.13
2025-08-29 45,877 54,928 -9,050 2.19
2025-08-15 54,928 51,962 +2,965 2.28
2025-07-31 51,962 36,529 +15,433 2.09
Showing 1–23 of 23 settlements
Key facts CIK 1958777 CUSIP 31573L204 Visit website Investor relations